Drug Type Biosimilar, Monoclonal antibody |
Synonyms Adalimumab Biosimilar (ISU Abxis Co., Ltd.), 阿达木单抗生物类似药(ISU Abxis Co., Ltd.) + [1] |
Target |
Mechanism TNF-α inhibitors(Tumor necrosis factor α inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Rheumatoid Arthritis | Preclinical | KR | 19 Jan 2021 |